Recipient NOD2/CARD15 variants:: A novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation

被引:43
作者
Hildebrandt, Gerhard C. [1 ]
Granell, Miguell [4 ]
Urbano-Lspizua, Alvaro [4 ]
Wolff, Daniel [5 ]
Hertenstein, Bernd [6 ]
Greinix, Hildegard T. [7 ]
Brenmoehl, Julia [1 ]
Schulz, Christian [2 ]
Dickinson, Anne M. [8 ,9 ]
Hahn, Joachim [1 ]
Rogler, Gerhard [3 ]
Andreesen, Reinhard [1 ]
Holler, Ennst [1 ]
机构
[1] Univ Regensburg, Sch Med, Dept Hematol & Oncol, D-93053 Regensburg, Germany
[2] Univ Regensburg, Sch Med, Dept Pulmonol, D-93053 Regensburg, Germany
[3] Univ Regensburg, Sch Med, Dept Gastroenterol, D-93053 Regensburg, Germany
[4] Univ Barcelona, Fac Med, Dept Hematol, Barcelona 7, Spain
[5] Univ Rostock, Sch Med, Dept Hematol & Oncol, Rostock, Germany
[6] Hannover Med Sch, Dept Hematol, Hannover, Germany
[7] Vienna Med Univ, Dept Internal Med 1, Vienna, Austria
[8] Univ Newcastle, Sch Clin, Newcastle Upon Tyne, Tyne & Wear, England
[9] Univ Newcastle, Sci Labs, Newcastle Upon Tyne, Tyne & Wear, England
关键词
bronchiolitis obliterans; chronic GVHD; NOD2; stem cell transplantation;
D O I
10.1016/j.bbmt.2007.09.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bronchiolitis obliterans (BO) is a serious complication after allogeneic stem cell transplantation. We hypothesized that single nucleotide polymorphisms (SNPs) of the NOD2/CARD15 gene (= NOD2/CARD15 variants) contribute to changes in host defense and subsequent alloreaction, leading to BO. We analyzed 427 donor-recipient pairs for the association of NOD2/CARD15 variants (SNP8 [Arg702Trp], SNP12 [Gly908Arg], and SNP13 [Leu1007fsinsC]) with BO occurrence. Overall, 11 patients (2.6%) developed BO. The cumulative incidence of BO rose from 1.3 % in donor-recipient pairs without mutation to 18.7% in pairs with donor or recipient NOD2/CARD15 variants (P <.001). Recipient NOD2/CARD15 variants alone led to BO in 22.3% (P <.001), whereas donor variants alone associated with BO in 13.2% (P =.04). Multivariate analysis proved recipient but not donor NOD2/CARD15 variants to be a novel independent risk factor for BO development, and NOD2/CARD15 typing may help identify patients at increased risk for BO. (c) 2008 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 49 条
[11]   Bronchiolitis obliterans in chronic graft-versus-host disease: Analysis of risk factors and treatment outcomes [J].
Dudek, AZ ;
Mahaseth, H ;
DeFor, TE ;
Weisdorf, DJ .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (10) :657-666
[12]   Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome [J].
Duncker, C ;
Dohr, D ;
von Harsdorf, S ;
Duyster, J ;
Stefanic, M ;
Martini, C ;
Treiber, M ;
Hertenstein, B ;
Novotny, J ;
Arnold, R ;
Heimpel, H ;
Bergmann, L ;
Bunjes, D .
BONE MARROW TRANSPLANTATION, 2000, 25 (12) :1263-1268
[13]   Obliterative airway disease in rat tracheal allografts requires tumor necrosis factor alpha [J].
Farivar, AS ;
Mackinnon-Patterson, B ;
McCourtie, AS ;
Namkung, J ;
Ward, PA ;
Mulligan, MS .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2005, 78 (03) :190-197
[14]   Analysis of the CARD15 variants R702W, G908R and l1007fs in Italian IBD patients [J].
Giachino, D ;
van Duist, MM ;
Regazzoni, S ;
Gregori, D ;
Bardessono, M ;
Salacone, P ;
Scaglione, N ;
Sostegni, R ;
Sapone, N ;
Bresso, F ;
Sambataro, A ;
Gaia, E ;
Pera, A ;
Astegiano, M ;
De Marchi, M .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2004, 12 (03) :206-212
[15]  
Granell M, 2006, HAEMATOLOGICA, V91, P1372
[16]   NOD2 mutations and Crohn's disease: are Paneth cells and their antimicrobial peptides the link? [J].
Grimm, MC ;
Pavli, P .
GUT, 2004, 53 (11) :1558-1560
[17]   Lung epithelium as a sentinel and effector system in pneumonia molecular mechanisms of pathogen recognition and signal transduction [J].
Hippenstiel, Stefan ;
Opitz, Bastian ;
Schmeck, Bernd ;
Suttorp, Norbert .
RESPIRATORY RESEARCH, 2006, 7 (1)
[18]   CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells [J].
Hisamatsu, T ;
Suzuki, M ;
Reinecker, HC ;
Nadeau, WJ ;
McCormick, BA ;
Podolsky, DK .
GASTROENTEROLOGY, 2003, 124 (04) :993-1000
[19]  
HOLLAND HK, 1988, BLOOD, V72, P621
[20]   Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation [J].
Holler, E ;
Rogler, G ;
Herfarth, H ;
Brenmoehl, J ;
Wild, PJ ;
Hahn, J ;
Eissner, G ;
Schölmerich, J ;
Andreesen, R .
BLOOD, 2004, 104 (03) :889-894